메뉴 건너뛰기




Volumn 120, Issue 24, 2012, Pages 4667-4668

Platelets signal and tumors take off

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 6; PACLITAXEL; SILTUXIMAB; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84870743628     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-09-457325     Document Type: Note
Times cited : (8)

References (10)
  • 1
    • 84870756108 scopus 로고    scopus 로고
    • Platelets increase the proliferation of ovarian cancer cells
    • Cho MS, Bottsford-Miller J, Vasquez HG, et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012;120(24):4869-4872.
    • (2012) Blood , vol.120 , Issue.24 , pp. 4869-4872
    • Cho, M.S.1    Bottsford-Miller, J.2    Vasquez, H.G.3
  • 2
    • 0014324610 scopus 로고
    • Antimetastatic effects associated with platelet reduction
    • Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968;61(1):46-52.
    • (1968) Proc Natl Acad Sci U S A. , vol.61 , Issue.1 , pp. 46-52
    • Gasic, G.J.1    Gasic, T.B.2    Stewart, C.C.3
  • 3
    • 3142592165 scopus 로고    scopus 로고
    • Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
    • DOI 10.1182/blood-2004-02-0434
    • Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood. 2004;104(2):397-401. (Pubitemid 38900020)
    • (2004) Blood , vol.104 , Issue.2 , pp. 397-401
    • Camerer, E.1    Qazi, A.A.2    Duong, D.N.3    Cornelissen, I.4    Advincula, R.5    Coughlin, S.R.6
  • 5
    • 81255205399 scopus 로고    scopus 로고
    • Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
    • Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576-590.
    • (2011) Cancer Cell. , vol.20 , Issue.5 , pp. 576-590
    • Labelle, M.1    Begum, S.2    Hynes, R.O.3
  • 6
    • 79251478398 scopus 로고    scopus 로고
    • Contribution of platelets to tumour metastasis
    • Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123-134.
    • (2011) Nat Rev Cancer. , vol.11 , Issue.2 , pp. 123-134
    • Gay, L.J.1    Felding-Habermann, B.2
  • 7
    • 84863115303 scopus 로고    scopus 로고
    • Paraneoplastic thrombocytosis in ovarian cancer
    • Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012; 366(7):610-618.
    • (2012) N Engl J Med , vol.366 , Issue.7 , pp. 610-618
    • Stone, R.L.1    Nick, A.M.2    McNeish, I.A.3
  • 8
    • 84860280934 scopus 로고    scopus 로고
    • Are we ready to recommend aspirin for cancer prevention?
    • Chan AT, Cook NR. Are we ready to recommend aspirin for cancer prevention? Lancet. 2012;379(9826): 1569-1571.
    • (2012) Lancet. , vol.379 , Issue.9826 , pp. 1569-1571
    • Chan, A.T.1    Cook, N.R.2
  • 9
    • 84863412124 scopus 로고    scopus 로고
    • Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
    • Rothwell PM, Price JF, Fowkes FG, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012; 379(9826):1602-1612.
    • (2012) Lancet , vol.379 , Issue.9826 , pp. 1602-1612
    • Rothwell, P.M.1    Price, J.F.2    Fowkes, F.G.3
  • 10
    • 84863399038 scopus 로고    scopus 로고
    • Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
    • Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379(9826):1591-1601.
    • (2012) Lancet. , vol.379 , Issue.9826 , pp. 1591-1601
    • Rothwell, P.M.1    Wilson, M.2    Price, J.F.3    Belch, J.F.4    Meade, T.W.5    Mehta, Z.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.